AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $109.3M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| RCE | Superbug awareness | 24/04/18 | 0 | 24 | |||
|
|||||||
| RCE | Ann: Pharmaceutical Expert Joins Board of Directors | 24/04/18 | 0 | 80 | |||
|
|||||||
| RCE | Ann: Additional AU$861,590 R&D Tax Incentive Rebate Received | 23/04/18 | 3 | 595 | |||
|
|||||||
| RCE | Ann: April Funding Update | 23/04/18 | 5 | 1.3K | |||
|
|||||||
| RCE | Ann: RECCE Antibiotic International Media Attention | 21/04/18 | 2 | 461 | |||
|
|||||||
| RCE | Ann: Meeting with US FDA on Phase I Clinical Trial for RECCE 327 | 16/03/18 | 3 | 1.0K | |||
|
|||||||
| RCE | Ann: Recce Half Yearly Report and Appendix 4D | 28/02/18 | 0 | 243 | |||
|
|||||||
See All Discussions
ASX News